Tasmar is a prescription medication that is approved for treating the symptoms of Parkinson's disease. This eMedTV page takes a closer look at Tasmar, including information on how it works, potential side effects, and tips on when and how to take it.
The most serious Tasmar side effect is liver failure. This page of the eMedTV library explains how side effects of Tasmar can become more significant over time. This article also provides a list of common and serious side effects seen with the drug.
Tasmar is used for treating adults who have Parkinson's disease. This selection from the eMedTV Web site discusses Tasmar uses in more detail, including information on how the medication works and details on when it should not be used.
The recommended starting Tasmar dosage for treating Parkinson's disease is 100 mg three times daily. This eMedTV resource describes the factors that may affect your Tasmar dose and provides tips on when and how to use the medication.
Warfarin and MAOIs are among the medicines that can cause negative interactions with Tasmar. This eMedTV page lists other medicines that can cause Tasmar drug interactions and describes the problems that may occur when these drugs are taken together.
Tasmar can cause dangerous conditions, such as liver failure and kidney damage. This eMedTV Web article contains other important Tasmar warnings and precautions to be aware of before using this drug, including a list of those who should avoid it.
Vomiting and difficulty breathing are some of the reported symptoms of a Tasmar (tolcapone) overdose. This eMedTV article lists other potential symptoms of a Tasmar overdose and describes some of the treatment options that are available.
It is not known whether it is safe to use Tasmar (tolcapone) during pregnancy. This page of the eMedTV archives offers more information on Tasmar and pregnancy, and describes the problems the drug caused when it was given to pregnant animals.
It is not known if Tasmar (tolcapone) is safe for women who are breastfeeding. This eMedTV page further discusses Tasmar and breastfeeding, and explains why research indicates that this drug will pass through breast milk and may cause problems.
At this time, there is no generic Tasmar (tolcapone) available in the United States. This eMedTV page explains why no generic versions of the drug are likely to become available until 2012 and discusses the difference between Tasmar and tolcapone.
| Referring Pages | Articles |
